Epitranscriptomics of cardiovascular diseases (Review).
PMID:34791505
Machine learning applications in RNA modification sites prediction.
PMID:34712397
Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer.
PMID:34630524
BERT-m7G: A Transformer Architecture Based on BERT and Stacking Ensemble to Identify RNA N7-Methylguanosine Sites from Sequence Information.
PMID:34484416
m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma.
PMID:34268304
Weakly supervised learning of RNA modifications from low-resolution epitranscriptome data.
PMID:34252943
MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma.
PMID:34244479
Recent advances in functional annotation and prediction of the epitranscriptome.
PMID:34136099
Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
PMID:33928086
m7GDisAI: N7-methylguanosine (m7G) sites and diseases associations inference based on heterogeneous network.
PMID:33761868
HN-CNN: A Heterogeneous Network Based on Convolutional Neural Network for m7 G Site Disease Association Prediction.
PMID:33747055
m5UPred: A Web Server for the Prediction of RNA 5-Methyluridine Sites from Sequences.
PMID:33230471
RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis.
PMID:33010174
Prediction of RNA Methylation Status From Gene Expression Data Using Classification and Regression Methods.
PMID:32733123
Bioinformatics approaches for deciphering the epitranscriptome: Recent progress and emerging topics.
PMID:32670500
PSI-MOUSE: Predicting Mouse Pseudouridine Sites From Sequence and Genome-Derived Features.
PMID:32565674